当前位置:首页 / 人工智能驱动下结直肠癌早期筛查和早期诊断技术的临床转化与挑战
| 更新时间:2026-03-05
|
人工智能驱动下结直肠癌早期筛查和早期诊断技术的临床转化与挑战
Clinical translation and challenges of artificial intelligence⁃driven early screening and diagnostic technologies for colorectal cancer

广西医学 页码:173-179

作者机构:田子涵,在读硕士研究生,研究方向为消化道肿瘤早筛。

基金信息:国家自然科学基金课题青年项目(82100632);北京华夏肿瘤防治研究院-2023年度早癌规范化能力提升项目(202401)

DOI:10.11675/j.issn.0253⁃4304.2026.02.03

  • 中文简介
  • 英文简介
  • 参考文献

结直肠癌(CRC)作为全球第三大常见恶性肿瘤,对人类健康构成重大威胁,其高死亡率与早期筛查和早期诊断手段的局限性密切相关。人工智能(AI)技术通过整合多模态数据,为CRC的早期筛查和早期诊断提供了突破性的解决方案。然而,AI技术的临床转化仍面临数据异质性、算法可解释性不足、监管框架滞后及医疗资源分配不均等诸多挑战。本文通过对国内外相关文献的深入梳理与分析,对AI技术在CRC早期筛查和早期诊断领域中的技术创新进行综述,并着重探讨AI技术临床转化所面临的挑战,旨在为后续更好地利用AI技术识别早期CRC提供思路和建议。

Colorectal cancer (CRC), as the third most common malignant tumor globally, poses a significant threat to human health, with its high mortality being strongly linked to limitations in early screening and diagnostic tools. Artificial intelligence (AI) technology offers breakthrough solutions for early screening and diagnosis of CRC through the integration of multimodal data. However, the clinical translation of AI technology still faces multiple challenges, including data heterogeneity, insufficient algorithm interpretability, lagging regulatory frameworks, and uneven distribution of medical resources, etc. Based on an in⁃depth review and analysis of relevant domestic and international literature, this paper comprehensively summarizes the technological innovations of AI technology in the field of early screening and diagnosis of CRC. It particularly focuses on exploring the clinical translation challenges faced by AI technology, with the aim of offering insights and recommendations to better leverage AI for identifying early⁃stage CRC.

21

浏览量

2

下载量

0

CSCD

工具集